Literature DB >> 366793

The platelet dense tubular system: its relationship to prostaglandin synthesis and calcium flux.

J M Gerrard, J G White, D A Peterson.   

Abstract

The platelet dense tubular system, an internal smooth endoplasmic reticulum membrane system occupies a pivotal position in the initiation and modulation of platelet activation. The best available evidence suggests platelet prostaglandin and thromboxane synthesis and an internal calcium store critical to platelet activation are both found in the platelet dense tubular system. Studies of the structural, physiologic and chemical properties of thromboxane A2 support the concept that this product of platelet prostaglandin synthesis acts to carry the calcium from the dense tubular system into the cytoplasm where the calcium is released to initiate contraction of the platelet contractile protein. Evaluation of platelet phospholipase A2 suggests that calcium may be critical to activation of this enzyme. Two of the steps occurring during platelet activation which appear to require calcium 1) phospholipase A2 acting as the critical carrier of calcium from one location to the other.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 366793

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  13 in total

1.  Biochemical mechanisms in 5-hydroxytryptamine-induced human platelet aggregation.

Authors:  F de Clerck; B Xhonneux; R van de Wiele
Journal:  Agents Actions       Date:  1985-12

2.  Protein kinase C isoform ε negatively regulates ADP-induced calcium mobilization and thromboxane generation in platelets.

Authors:  Yamini S Bynagari-Settipalli; Parth Lakhani; Jianguo Jin; Kamala Bhavaraju; Mario C Rico; Soochong Kim; Donna Woulfe; Satya P Kunapuli
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-02-23       Impact factor: 8.311

Review 3.  Thiol isomerases in thrombus formation.

Authors:  Bruce Furie; Robert Flaumenhaft
Journal:  Circ Res       Date:  2014-03-28       Impact factor: 17.367

4.  Platelet heterogeneity and dense tubular system changes on activation.

Authors:  R Yarom; G Lijovetzky; Y Havivi
Journal:  Experientia       Date:  1981-01-15

5.  Inhibition of 5-hydroxytryptamine-induced and -amplified human platelet aggregation by ketanserin (R 41,468), a selective 5-HT2-receptor antagonist. 1982.

Authors:  F de Clerck; J L David; P A Janssen
Journal:  Agents Actions       Date:  1994-12

6.  Effect of calcium, magnesium, and cytochalasin B on arachidonic acid-induced neutrophil aggregation.

Authors:  J T O'Flaherty
Journal:  Inflammation       Date:  1980-03       Impact factor: 4.092

7.  Ca2+ accumulation into acidic organelles mediated by Ca2+- and vacuolar H+-ATPases in human platelets.

Authors:  José J López; Cristina Camello-Almaraz; José A Pariente; Ginés M Salido; Juan A Rosado
Journal:  Biochem J       Date:  2005-08-15       Impact factor: 3.857

8.  A potential role for extracellular nitric oxide generation in cGMP-independent inhibition of human platelet aggregation: biochemical and pharmacological considerations.

Authors:  Michael S Crane; Adriano G Rossi; Ian L Megson
Journal:  Br J Pharmacol       Date:  2005-03       Impact factor: 8.739

9.  Localization of cyclo-oxygenase and thromboxane synthetase in human platelet intracellular membranes.

Authors:  F Carey; S Menashi; N Crawford
Journal:  Biochem J       Date:  1982-06-15       Impact factor: 3.857

10.  Inhibition of 5-hydroxytryptamine-induced and -amplified human platelet aggregation by ketanserin (R 41 468), a selective 5-HT2-receptor antagonist.

Authors:  F de Clerck; J L David; P A Janssen
Journal:  Agents Actions       Date:  1982-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.